Health and Medical News Journalist
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) confirmed Sunday that the international outbreak of the rare Andes hantavirus has reached the United States. Following the repatriation of 17 American citizens from a luxury cruise ship, one passenger has tested mildly positive for the virus via PCR testing, while a second is currently exhibiting mild symptoms. In a high-stakes medical operation, both individuals were transported via State Department airlift in specialized biocontainment units to Nebraska, where they will receive care at elite emerging pathogen treatment centers. While the 38% case fatality rate of the virus is high, federal officials emphasize that the immediate risk to the American public remains exceptionally low.
A Voyage Interrupted: The MV Hondius Outbreak
The current health crisis is traced back to the MV Hondius, a Dutch-flagged expedition vessel. The ship departed Argentina on April 1 for what was intended to be a 33-day journey across the South Atlantic. However, the voyage turned tragic as a cluster of respiratory illnesses emerged.
As of May 11, 2026, the World Health Organization (WHO) has documented eight cases linked to the vessel—six confirmed and two suspected. The human cost has been significant, with three recorded deaths: two Dutch nationals and one German citizen.
Current Outbreak Metrics at a Glance
| Metric | Status / Data |
| Total Reported Cases | 8 (6 confirmed, 2 suspected) |
| Confirmed Fatalities | 3 (Dutch and German nationals) |
| Case Fatality Ratio | ~38% |
| U.S. Citizens Under Care | 2 (1 PCR-positive, 1 symptomatic) |
| U.S. Repatriation Pool | 17 total passengers |
Decoding the Andes Strain: A Unique Viral Threat
Hantaviruses generally cause Hantavirus Pulmonary Syndrome (HPS), a severe and often fatal respiratory disease. However, the Andes strain is a scientific outlier. Unlike the hantaviruses typically found in the American Southwest (such as the Sin Nombre virus), the Andes strain is the only known hantavirus capable of person-to-person transmission.
The incubation period for the virus is notably long, ranging from 4 to 42 days, making it difficult to track during the early stages of an outbreak.
Symptom Progression
-
Early Phase: Fever, fatigue, and severe muscle aches (myalgia) in the thighs, hips, and back. Patients often mistake this for a standard seasonal flu.
-
Gastrointestinal Distress: Approximately 50% of patients experience nausea, vomiting, diarrhea, and acute abdominal pain.
-
Late Phase (Critical): Between 4 to 10 days after the first symptoms, the disease progresses rapidly. Lungs begin to fill with fluid, leading to severe shortness of breath, coughing, and chest tightness.
Mechanisms of Transmission
Most hantaviruses are “dead-end” infections in humans, meaning the virus stops with the infected person. They are typically contracted via:
-
Aerosolization: Breathing in dust contaminated with rodent urine or droppings.
-
Direct Contact: Touching contaminated surfaces and then touching the mouth or nose.
However, the Andes strain’s ability to move between humans changes the public health calculus. Transmission typically occurs through close, prolonged contact—such as within a household or between intimate partners—during the early symptomatic phase.
“Only one strain, known as Andes virus, has been documented to potentially spread from person to person, although such transmission is rare and typically requires close contact,” noted researchers from the University of Florida.
Expert Perspective: Low Risk, High Vigilance
Despite the high fatality rate, which some experts place between 40% and 50% for New World hantaviruses, the geographic reality provides a buffer for the U.S. population. The specific rodents that carry the Andes strain are not native to North America.
“While this is a serious incident, WHO assesses the public health risk as low,” stated Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.
The U.S. response has been surgical. The affected passengers are being treated at ASPR Regional Emerging Special Pathogen Treatment Centers (RESPTC). These facilities are designed for the highest levels of containment, ensuring that the virus does not enter the community.
What Travelers and the Public Need to Know
For health-conscious citizens, the primary takeaway is awareness rather than alarm. If you are traveling to endemic regions in South America (specifically parts of Argentina and Chile), the CDC recommends the following:
-
Rodent Avoidance: Avoid areas with signs of rodent infestation (nests/droppings).
-
Hygiene: Wash hands frequently with soap and water.
-
Social Distancing: Avoid close contact with individuals showing flu-like symptoms if you are in a known outbreak zone.
-
No Sharing: Do not share eating utensils or drinks with symptomatic individuals.
For those in the United States without a history of travel to the South Atlantic or South America, the risk of contracting the Andes strain is virtually zero.
Scientific Limitations and the Path Forward
Health officials remain cautious because of several “unknowns” in the MV Hondius case:
-
Origin: No rodents were found on the ship. Scientists hypothesize that passengers were exposed during land-based excursions in Argentina or Chile before boarding.
-
Extended Monitoring: Because the incubation period can last up to eight weeks, more cases could emerge from the 29 individuals who disembarked on April 24.
-
Treatment: There is currently no FDA-approved vaccine or specific antiviral for Andes virus. Treatment is limited to “supportive care,” which often involves intensive care and mechanical ventilation.
This outbreak serves as a stark reminder of how global travel can facilitate the movement of rare pathogens. However, the rapid identification and biocontainment of the U.S. cases suggest that the public health infrastructure is functioning as intended.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
Official Reports & Citations
-
U.S. Department of Health and Human Services (HHS). (2026, May 10). Statement on Repatriation of Passengers from MV Hondius.